Taylor Davis is an associate in the firm's Intellectual Property Department. His practice focuses on intellectual property litigation and counseling and other technology-related commercial disputes. He has assisted clients in the life sciences industry, including pharmaceutical and biotechnology companies.
Taylor has worked on teams representing clients in patent litigation and has also worked on matters related to trademark and copyright infringement litigation. His related experience includes representing clients in antitrust matters.
Yale University, B.S., cum laude, Phi Beta Kappa, 2013
Bar and Court Admissions
BAR ADMISSIONS
New York
Massachusetts
COURT ADMISSIONS
U.S. District Court for the Southern District of New York
U.S. District Court for the Eastern District of New York
U.S. Court of Appeals for the Federal Circuit
Experience
Represents Enanta Pharmaceuticals in patent litigation against Pfizer concerning the assertion of a patent covering Pfizer’s COVID-19 oral antiviral.
Represented Dana-Farber in a case against Bristol-Myers Squibb and Ono Pharmaceuticals, asserting claims for unjust enrichment and unfair competition for depriving Dana-Farber of its co-ownership rights under eight patents directed to cancer immunotherapy. On the eve of trial, in the face of Dana-Farber’s claim for hundreds of millions of dollars in damages, Defendants settled, making a substantial lump sum payment to Dana-Farber and agreeing to make potential additional payments, contingent on future events.
Represented Krystal Biotech in litigation brought by PeriphaGen alleging misappropriation of trade secrets and acts of “unfair competition” in connection with Krystal’s vector development. PeriphaGen also sought to add two of its employees as inventors to several of Krystal’s U.S. patents directed to methods of treating skin disorders by delivering certain genes using replication-defective HSV-1 vectors.
PROFESSIONAL EXPERIENCE
Post-baccalaureate Intramural Research Training Award Fellow, National Institutes of Health, 2013-2015
Other Publications
"Recurrent mutations in the basic domain of TWIST2 cause Ablepharon macrostomia and Barber-Say syndromes," American Journal of Human Genetics 87, 99-110. (Co-first author with Marchegiani S, Tessadori F, et al.) (2015)
"A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3," (with Yamamoto S, Adams DR, Markello TC, Gahl WA, Bellen HJ, Wangler MF, Malicdan MCV) American Journal of Human Genetics 100, 128-137 (2017)
"Synucleins regulate the kinetics of synaptic vesicle endocytosis," The Journal of Neuroscience 34, 9364-9376 (co-author with Vargas, KJ, Makani, S, Westphal, CH, Castillo, PE, and Chandra, SS) (2014)
Honors & Involvement
HONORS
Best Lawyers: Ones to Watch
Litigation - Patent (2026, 2027)
Litigation - Intellectual Property (2026, 2027)
World Intellectual Property Review, WIPR Leaders (2024)
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
